相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige et al.
HEPATOLOGY RESEARCH (2021)
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige et al.
JOURNAL OF GASTROENTEROLOGY (2021)
CD14: Biology and role in the pathogenesis of disease
Zhenghao Wu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2019)
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Evan Bolyen et al.
NATURE BIOTECHNOLOGY (2019)
Phase 3 drug pipelines in the treatment of non-alcoholic steatohepatitis
Yoshio Sumida et al.
HEPATOLOGY RESEARCH (2019)
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Laurent Castera et al.
GASTROENTEROLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Diagnosis and treatment of small intestinal bacterial overgrowth
Francesca Romana Ponziani et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
Jerome Boursier et al.
HEPATOLOGY (2016)
DADA2: High-resolution sample inference from Illumina amplicon data
Benjamin J. Callahan et al.
NATURE METHODS (2016)
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
Maria Nicoline Baandrup Kristiansen et al.
WORLD JOURNAL OF HEPATOLOGY (2016)
Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection
Pedro P. Hernandez et al.
NATURE IMMUNOLOGY (2015)
Mucin glycan foraging in the human gut microbiome
Louise E. Tailford et al.
FRONTIERS IN GENETICS (2015)
The colonic mucus protection depends on the microbiota
Ana M. Rodriguez-Pineiro et al.
GUT MICROBES (2015)
Interactions Between the Intestinal Microbiome and Liver Diseases
Bernd Schnabl et al.
GASTROENTEROLOGY (2014)
Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease
Pierre Bedossa
HEPATOLOGY (2014)
Adipocytokines in obesity and metabolic disease
Haiming Cao
JOURNAL OF ENDOCRINOLOGY (2014)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Julia Kozlitina et al.
NATURE GENETICS (2014)
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
Jason R. Clapper et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
Masahiko Matsumoto et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)
Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis
Yuji Ogawa et al.
PLOS ONE (2013)
Role of CD14 in host protection against infections and in metabolism regulation
Ivan Zanoni et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease
Dawn M. Torres et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
Pierre Bedossa et al.
HEPATOLOGY (2012)
Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-Positive B-cell population
Hiroyoshi Doi et al.
HEPATOLOGY (2012)
UCHIME improves sensitivity and speed of chimera detection
Robert C. Edgar et al.
BIOINFORMATICS (2011)
FLASH: fast length adjustment of short reads to improve genome assemblies
Tanja Magoc et al.
BIOINFORMATICS (2011)
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
Jacques Amar et al.
EMBO MOLECULAR MEDICINE (2011)
Elevated endotoxin levels in non-alcoholic fatty liver disease
Alison L. Harte et al.
JOURNAL OF INFLAMMATION-LONDON (2010)
Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease
Luca Miele et al.
HEPATOLOGY (2009)
Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice
Roberto Roncon-Albuquerque et al.
LIFE SCIENCES (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis
Chantal A. Rivera et al.
JOURNAL OF HEPATOLOGY (2007)
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani et al.
DIABETES (2007)
Toll-like receptor signaling in the liver
Robert F. Schwabe et al.
GASTROENTEROLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Initial responses to endotoxins and Gram-negative bacteria
D Heumann et al.
CLINICA CHIMICA ACTA (2002)
Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria
D Le Roy et al.
JOURNAL OF IMMUNOLOGY (2001)
Nonalcoholic steatohepatitis: Definition and pathology
EM Brunt
SEMINARS IN LIVER DISEASE (2001)
分享论文
